Nordic Pharma (Pharmaceuticals) Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
300
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
- Investments
-
3
Nordic Pharma (Pharmaceuticals) General Information
Description
Operator of a generic pharmaceutical company intended to develop peptide-based drugs and biotechnology derived medicines. The company manufactures and markets peptide-based drugs and biotechnology derived medicines, as well as patient-friendly drug delivery systems in targeted markets enabling patients, care providers and pharmacies to reduce cost of treatment and increase quality of treatment.
Contact Information
Website
www.nordicpharmausa.comCorporate Office
- 1235 Westlakes Drive
- Suite 205
- Berwyn, PA 19312
- United States
Corporate Office
- 1235 Westlakes Drive
- Suite 205
- Berwyn, PA 19312
- United States
Nordic Pharma (Pharmaceuticals) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nordic Pharma (Pharmaceuticals) Patents
Nordic Pharma (Pharmaceuticals) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20050244495-A1 | Adjusting release profile; urogenital disorders; blood disorders; edema | Inactive | 04-Mar-2004 | ||
| US-20090048341-A1 | Oral administering; controlling blood concentration; sustained release; urogenital disorders; blood disorders | Active | 04-Mar-2004 | ||
| US-8273795-B2 | Oral administering; controlling blood concentration; sustained release; urogenital disorders; blood disorders | Inactive | 04-Mar-2004 | ||
| US-20050245614-A1 | Oral administering; controlling blood concentration; urogenital disorders; blood disorders | Inactive | 04-Mar-2004 | ||
| US-20080280981-A1 | Oral dosage form; controlling blood concentration; urogenital disorders; edema; blood coagulation disorders in patient undergoing dental surgery | Inactive | 04-Mar-2004 | A61K31/19 |
Nordic Pharma (Pharmaceuticals) Signals
Nordic Pharma (Pharmaceuticals) Investments & Acquisitions (3)
Nordic Pharma (Pharmaceuticals)’s most recent deal was a Merger/Acquisition with Visant Medical. The deal was made on 18-Dec-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Visant Medical | 18-Dec-2023 | Merger/Acquisition | Therapeutic Devices | ||
| Ferring International (Global Rights to LYSTEDA) | 01-Dec-2020 | Corporate Asset Purchase | Buildings and Property | ||
| Luitpold Pharmaceuticals and AlphaForce (Six ANDAs) | 01-Mar-2017 | Corporate Asset Purchase | Pharmaceuticals |
Nordic Pharma (Pharmaceuticals) FAQs
-
When was Nordic Pharma (Pharmaceuticals) founded?
Nordic Pharma (Pharmaceuticals) was founded in 2015.
-
Where is Nordic Pharma (Pharmaceuticals) headquartered?
Nordic Pharma (Pharmaceuticals) is headquartered in Berwyn, PA.
-
What is the size of Nordic Pharma (Pharmaceuticals)?
Nordic Pharma (Pharmaceuticals) has 300 total employees.
-
What industry is Nordic Pharma (Pharmaceuticals) in?
Nordic Pharma (Pharmaceuticals)’s primary industry is Pharmaceuticals.
-
Is Nordic Pharma (Pharmaceuticals) a private or public company?
Nordic Pharma (Pharmaceuticals) is a Private company.
-
What is Nordic Pharma (Pharmaceuticals)’s current revenue?
The current revenue for Nordic Pharma (Pharmaceuticals) is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process